A0015873 Screening compound: 2-{[(1H-1,3-benzodiazol-2-yl)methyl]sulfanyl}-N-[(2-chlorophenyl)methyl]-4-oxo-3-(2-phenylethyl)-3,4-dihydroquinazoline-7-carboxamide

A0015873 Screening compound: 2-{[(1H-1,3-benzodiazol-2-yl)methyl]sulfanyl}-N-[(2-chlorophenyl)methyl]-4-oxo-3-(2-phenylethyl)-3,4-dihydroquinazoline-7-carboxamide
A0015873 Screening compound: 2-{[(1H-1,3-benzodiazol-2-yl)methyl]sulfanyl}-N-[(2-chlorophenyl)methyl]-4-oxo-3-(2-phenylethyl)-3,4-dihydroquinazoline-7-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound A0015873
2-{[(1H-1,3-benzodiazol-2-yl)methyl]sulfanyl}-N-[(2-chlorophenyl)methyl]-4-oxo-3-(2-phenylethyl)-3,4-dihydroquinazoline-7-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

A0015873

Molecular Formula

C32H26ClN5O2S (C32 H26 ClN5 O2 S)

Compound Name

2-{[(1H-1,3-benzodiazol-2-yl)methyl]sulfanyl}-N-[(2-chlorophenyl)methyl]-4-oxo-3-(2-phenylethyl)-3,4-dihydroquinazoline-7-carboxamide

IUPAC name

2-{[(1H-13-benzodiazol-2-yl)methyl]sulfanyl}-N-[(2-chlorophenyl)methyl]-4-oxo-3-(2-phenylethyl)-34-dihydroquinazoline-7-carboxamide

SMILES

O=C(c(cc1)cc(N=C(N2CCc3ccccc3)SCc3nc(cccc4)c4[nH]3)c1C2=O)NCc(cccc1)c1Cl

InChI

InChI=1S/C32H26ClN5O2S/c33-25-11-5-4-10-23(25)19-34-30(39)22-14-15-24-28(18-22)37-32(38(31(24)40)17-16-21-8-2-1-3-9-21)41-20-29-35-26-12-6-7-13-27(26)36-29/h1-15,18H,16-17,19-20H2,(H,34,39)(H,35,36)

InChI Key

OXQUDIGZKHMMFP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD02111142

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

580.11

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

6.294

Distribution Coefficient, logD

6.294

Water Solubility, LogSw

-6.13

Polar Surface Area

70.444

Acid Dissociation Constant (pKa)

11.43

Base Dissociation Constant (pKb)

4.26

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

12.50

A0015873 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PI3K-Targeted Library (17255 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with A0015873 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound A0015873?
Check Price and Availability of A0015873, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of A0015873 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for A0015873
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for A0015873
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of A0015873 available by request